clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Chlamydophila Infections D023521 4 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Renal Insufficiency D051437 8 associated lipids
Immune Reconstitution Inflammatory Syndrome D054019 1 associated lipids
Buruli Ulcer D054312 1 associated lipids
Extensively Drug-Resistant Tuberculosis D054908 1 associated lipids
Leprosy, Paucibacillary D056005 2 associated lipids
Upper Extremity Deep Vein Thrombosis D056824 1 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Huang YK et al. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. 2012 J Dig Dis pmid:22435509
Brož P et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. 2012 Allergy pmid:22435670
Hojsak I et al. Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience. 2012 Eur. J. Pediatr. pmid:22430353
Koutsoubari I et al. Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. 2012 Pediatr Allergy Immunol pmid:22433020
Lin YH and Liu TC Mycobacterium chelonae infection involving the auricle. 2012 QJM pmid:21908384
Ji R et al. Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy. 2012 Gastrointest. Endosc. pmid:22325805
Walkey AJ and Wiener RS Macrolide antibiotics and survival in patients with acute lung injury. 2012 Chest pmid:22116799
Raj JM and Raj SM Concern about the efficacy of clarithromycin containing standard triple therapy in the eradication of Helicobacter pylori infection in Malaysia. 2012 Med. J. Malaysia pmid:23770883
Kim SY et al. Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea. 2012 Br J Clin Pharmacol pmid:21689141
Togami K et al. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections. 2012 J Aerosol Med Pulm Drug Deliv pmid:22360316
Shiotani A et al. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. 2012 J. Gastroenterol. pmid:22382634
Ding FM et al. Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection. 2012 Respirology pmid:22404374
Kadayifci A et al. Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection. 2012 Helicobacter pmid:22404442
Gisbert JP and McNicholl AG Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital. 2012 Helicobacter pmid:22404448
Hiramatsu M et al. Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. 2012 Ann. Thorac. Surg. pmid:22119119
Salmon JH et al. Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation. 2012 Joint Bone Spine pmid:22405857
Katayama M et al. Interaction of clarithromycin with cyclosporine in cats: pharmacokinetic study and case report. 2012 J. Feline Med. Surg. pmid:22412163
Bobacheva TIu [The treatment of chronic polypous rhinosinusitis in the postoperative period with low doses of clarithromycin]. 2012 Vestn. Otorinolaringol. pmid:23011378
Omoruyi OJ et al. Metachronous Mycobacterium terrae complex tenosynovitis of the hand. 2012 J Hand Surg Eur Vol pmid:22415428
Ohe M and Hashino S Successful treatment of eosinophilic gastroenteritis with clarithromycin. 2012 Korean J. Intern. Med. pmid:23269887
Breda R et al. [Mycobacterium massiliense bone infection]. 2012 Med Mal Infect pmid:22154522
Zarogoulidis P et al. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. 2012 Eur. J. Clin. Pharmacol. pmid:22105373
Bruin JP et al. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates. 2012 Diagn. Microbiol. Infect. Dis. pmid:22100012
van Ingen J et al. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. 2012 Int. J. Antimicrob. Agents pmid:22099521
Bondon-Guitton E et al. Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database. 2012 J. Clin. Periodontol. pmid:22519416
Konorev MR [Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy]. 2012 Ter. Arkh. pmid:23479993
Bosnar M et al. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity. 2012 J. Med. Chem. pmid:22697905
Bai J et al. Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation. 2012 Mediators Inflamm. pmid:22701274
Prechtl J et al. Monitoring of antibiotic resistance rates of Helicobacter pylori in Austrian children, 2002-2009. 2012 Pediatr. Infect. Dis. J. pmid:22094633
Deguchi R et al. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. 2012 J. Gastroenterol. Hepatol. pmid:22098133
Deng ZH et al. Influence of Helicobacter pylori infection on ghrelin levels in children. 2012 World J. Gastroenterol. pmid:23049220
Malfertheiner P et al. Helicobacter pylori: clinical management. 2012 Curr. Opin. Gastroenterol. pmid:23010682
Tepes B et al. Treatment of Helicobacter pylori infection 2012. 2012 Helicobacter pmid:22958154
Al Aukidy M et al. Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy. 2012 Sci. Total Environ. pmid:22967493
Sarker SA et al. Influence of Helicobacter pylori infection on gastric acid secretion in pre-school Bangladeshi children. 2012 Helicobacter pmid:22967116
Nishizawa T et al. Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy. 2012 J Clin Biochem Nutr pmid:22962528
Amin M et al. Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori. 2012 Int J Mol Sci pmid:22949839
Kwan BY and Rabheru K Manic episode associated with clarithromycin in a patient with medically treated depression. 2012 Prim Care Companion CNS Disord pmid:22943025
Cheung JP et al. Mycobacterium marinum infection of the hand and wrist. 2012 J Orthop Surg (Hong Kong) pmid:22933682
Kurinčič M et al. Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics. 2012 Int. J. Antimicrob. Agents pmid:22999765
Roccarina D et al. Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. 2012 Dig Liver Dis pmid:22743557
Tursi A et al. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. 2012 J Gastrointestin Liver Dis pmid:22720300
Giguère S et al. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi. 2012 Vet. Microbiol. pmid:22704561
O'Connor MB et al. Rituximab-induced pulmonary disease. 2012 Rheumatol. Int. pmid:21892654
Nakagawa T et al. [Multicenter study on clinical features and genetic characteristics of Mycobacterium avium strains from patients in Japan with lung disease caused by M. avium]. 2012 Kekkaku pmid:23367826
Kumar KV et al. Recurrent insulin injection abscesses: Atypical etiology. 2012 Indian J Endocrinol Metab pmid:22701833
Gochi M et al. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report]. 2012 Kekkaku pmid:23367833
Kim BJ et al. Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. 2012 PLoS ONE pmid:22693637
Karczewska E et al. Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland. 2012 Gastroenterol Res Pract pmid:22693490
Tuchman SA et al. Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. 2012 Adv Hematol pmid:22690220
Fujita M et al. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease. 2012 J. Infect. Chemother. pmid:21927844
Ojetti V et al. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. 2012 Gastroenterol Res Pract pmid:22690211
Dobrick N et al. [Legionnaires disease (legionella pneumonia)]. 2012 Praxis (Bern 1994) pmid:23147600
Ratcliffe AT and Ismail KM Intravenous macrolide use: a reminder of the dangers of rapid infusion rates. 2012 J Clin Anesth pmid:23101782
Robinson P et al. Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial. 2012 Pediatr. Pulmonol. pmid:22266895
English ML et al. Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies. 2012 Antimicrob. Agents Chemother. pmid:22290969
Brereton AS and El Teraifi H Mycobacterium malmoense: dissemination causes a popliteal aneurysm in a 74-year-old man. 2012 BMJ Case Rep pmid:22602841
Jigorel E and Houston JB Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes. 2012 Drug Metab. Dispos. pmid:22593038
Timour Q et al. Sudden death of cardiac origin and psychotropic drugs. 2012 Front Pharmacol pmid:22590457
Ogoshi T et al. A case of Good syndrome with pulmonary lesions similar to diffuse panbronchiolitis. 2012 Intern. Med. pmid:22576393
Conde-Álvarez R et al. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. 2012 PLoS Pathog. pmid:22589715
Schluger NW Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter? 2012 Am. J. Respir. Crit. Care Med. pmid:23071188
Li K and Haber RM Stevens-Johnson syndrome without skin lesions (Fuchs syndrome): a literature review of adult cases with Mycoplasma cause. 2012 Arch Dermatol pmid:22911206
Li H et al. [Clarithromycin combined with tanshinone for rhinosinusal and laryngeal radiation injury in patients with nasopharyngeal carcinoma after radiotherapy]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:22931614
Nakajima S et al. Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy. 2012 J. Gastroenterol. Hepatol. pmid:22486882
Gisbert JP Rescue Therapy for Helicobacter pylori Infection 2012. 2012 Gastroenterol Res Pract pmid:22536225
Lee MR et al. Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii). 2012 J. Clin. Microbiol. pmid:22933592
Lee RP et al. Mycobacterium chelonae infection after total knee arthroplasty: a case report. 2012 J Orthop Surg (Hong Kong) pmid:22535831
van de Streek J Reinterpretation of the monohydrate of clarithromycin from X-ray powder diffraction data as a trihydrate. 2012 Acta Crystallogr C pmid:22935507
Shaaban HS et al. Mycobacterium chelonae infection of the parotid gland. 2012 J Glob Infect Dis pmid:22529633
Farivar TN et al. Assessment of helicobacter pylori prevalence by scorpion real-time PCR in chronic tonsillitis patients. 2012 J Glob Infect Dis pmid:22529626
Buzás GM [Helicobacter pylori - 2012]. 2012 Orv Hetil pmid:22951408
Zheng Q et al. Occurrence and distribution of antibiotics in the Beibu Gulf, China: impacts of river discharge and aquaculture activities. 2012 Mar. Environ. Res. pmid:22525825
Misiewicz JJ Management of Helicobacter pylori-related disorders. 2012 Eur J Gastroenterol Hepatol pmid:22498902
Sereni G et al. Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. 2012 World J. Gastroenterol. pmid:22969227
Bajaj P et al. Locally delivered 0.5% clarithromycin, as an adjunct to nonsurgical treatment in chronic periodontitis with well-controlled type 2 diabetes: a randomized controlled clinical trial. 2012 J Investig Clin Dent pmid:22976782
Senhorinho GN et al. Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis. 2012 Anaerobe pmid:22609780
Lee HY et al. Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. 2012 Subst Abuse Treat Prev Policy pmid:22429858
Buyck JM et al. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. 2012 Clin. Infect. Dis. pmid:22573850
Shimizu T and Shimizu S Azithromycin inhibits mucus hypersecretion from airway epithelial cells. 2012 Mediators Inflamm. pmid:22577246
Mochizuki Y et al. Chronic mandibular osteomyelitis with suspected underlying synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: a case report. 2012 J Inflamm Res pmid:22427727
Farfan-Portet MI et al. Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data. 2012 Eur J Health Econ pmid:22427042
Mégraud F The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. 2012 Therap Adv Gastroenterol pmid:22423259
Scheel AH et al. Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report. 2012 Diagn Pathol pmid:22420484
Brüning J et al. Erythromycin A dimethyl sulfoxide disolvate 1.43-hydrate. 2012 Acta Crystallogr Sect E Struct Rep Online pmid:22412590
Noguchi S et al. Clarithromycin monohydrate: a synchrotron X-ray powder study. 2012 Acta Crystallogr Sect E Struct Rep Online pmid:22412567
Guillot S et al. Macrolide-resistant Bordetella pertussis infection in newborn girl, France. 2012 Emerging Infect. Dis. pmid:22608348
van Ingen J et al. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. 2012 Am. J. Respir. Crit. Care Med. pmid:22744719
Kobashi Y et al. Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin. 2012 Intern. Med. pmid:22821114
Morisset J et al. A case of difficult-to-treat eosinophilic asthma controlled with clarithromycin. 2012 Ann. Allergy Asthma Immunol. pmid:22727169
Calza P et al. Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass spectrometry. 2012 Rapid Commun. Mass Spectrom. pmid:22730089
Pereyre S et al. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. 2012 Emerging Infect. Dis. pmid:22305177
Butler CC et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. 2012 BMJ pmid:22302780
Anand TD et al. Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22296671
Trigo P and Fischer GW Managing atrial fibrillation in the elderly: critical appraisal of dronedarone. 2012 Clin Interv Aging pmid:22291468
Correia M et al. Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. 2012 PLoS ONE pmid:22529974
Altman JK and Platanias LC A new purpose for an old drug: inhibiting autophagy with clarithromycin. 2012 Leuk. Lymphoma pmid:22288786
Polat Z et al. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. 2012 Eur. J. Intern. Med. pmid:22284248
Siqueira JF et al. Pyrosequencing as a tool for better understanding of human microbiomes. 2012 J Oral Microbiol pmid:22279602
O'Brien DP et al. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. 2012 PLoS Negl Trop Dis pmid:22272368